 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
February 10–12, 2006
Welcome • Program • Faculty |
|
Program
| Friday, February 10, 2006 | |
| 6:00 pm | Welcome Reception |
| 7:00 pm | Opening Dinner & Hill Country Wine Tasting |
| 8:15–9:00 pm | KEYNOTE PRESENTATION Physical Inactivity and Obesity: A Society Out of Balance - Steven N. Blair, PED |
| Saturday, February 11, 2006 | |
| 8:00 am | THE METABOLIC SYNDROME: Past, Present, Future Moderator: Kathleen Wyne, MD, PhD |
| 8:05 am | The Rationale for the ATP III Defi nition and the AHA Guidelines - Scott Grundy, MD |
| 8:20 am | Why PCOS Should Be Considered as a Component of Metabolic Syndrome - Robert Wild, MD |
| 8:35 am | Why Disorders of Uric Acid Metabolism Should Be Considered as a Component of Metabolic Syndrome - Naim Maalouf, MD |
| 8:50 am | What Are the Future Directions in Metabolic Syndrome Research? - Steven Haffner, MD |
| 9:00 am | Summary and Panel Discussion |
| TREATMENT APPROACHES: Current & New Strategies for CV Risk Reduction | |
| 9:15 am | Effect of Cardiorespiratory Fitness on the Incidence of Metabolic Syndrome - Timothy Church, MD, PhD |
| 9:40 am | Optimal Diabetes Therapies to Improve Lipids and CVD Risk - Timothy Lyons, MD |
| 10:05 am | Cardiometabolic Risk Factor Improvement in Obese Patients: Novel Approaches - Steven Haffner, MD |
| 10:30 am | Coffee Break |
| 11:00 am | Lipid-lowering Therapy Following Acute Coronary Syndromes – How Low to Go, When to Start, and With What? - James A. de Lemos, MD |
| 11:25 am | Raising HDL: Current and Future Approaches - Darren McGuire, MD |
| 11:50 am | Strategies for the Aggressive Management of Triglycerides - Christie Ballantyne, MD |
| 12:15 pm | Lunch |
| 1:15 pm | SWLA Business Meeting |
| 1:30 pm | ATHEROGENIC LIPOPROTEINS: What's New in Risk Assessment, Biology & Targets of Treatment Moderator: Carl Rubenstein, MD |
| 1:30 pm | Clinical Applications of Advanced Lipid Testing - Peter Jones, MD |
| 1:50 pm | Characterization of apoA and apoB Containing Lipoprotein Particles and Their Clinical Significance - Petar Alaupovic, PhD |
| 2:10 pm | Panel Discussion |
| 2:20 pm | Antisense Inhibition of Apolipoprotein B with Resultant LDL-C Lowering - Mark Wedel, MD |
| 2:40 pm | New Pathways for Regulating LDL: A Novel Mutation in PCSK-9 - Jonathan Cohen, PhD |
| 3:00 pm | Adjourn |
| 4:00–5:45 pm | Practical Pedometer Course and 2-Mile Walk - Ralph La Forge, MSc For details, see the activity description on back cover. |
| Evening free | |
| Sunday, February 12, 2006 | |
| 8:00 am | Report From NLA Statin Safety Assessment Task Force - James McKenney, PharmD |
| 8:40 am | Atherosclerosis Imaging by CT – Current Status and Future Opportunities - Paolo Raggi, MD |
| GENDER, ETHNICITY & PREVENTION OF CARDIOVASCULAR DISEASE | |
| 9:00 am | Gender and Ethnic Differences in CRP Levels - Amit Khera, MD |
| 9:20 am | Special Needs of the African American Community - Tracie Collins, MD, MPH |
| 9:40 am | Successful Interventions in Hispanic and Native American Populations - Randy Burden, PharmD |
| 10:00 am | Novel Approaches to Prevention: The New Heart Telehealth Project - Richard Lueker, MD |
| 10:30 am–Noon | CONCURRENT WORKSHOP SERIES Registrants select two workshops. Each 45-minute workshop is repeated once. Clinical Management of Challenging Cases - Peter Jones, MD Atherosclerosis Imaging and Lipid Testing in Clinical Practice - Paolo Raggi, MD and Kevin Winfield, MD Key Considerations for Designing and Operating a Clinically Successful Lipid or Metabolic Syndrome Clinic - Ralph La Forge, MSc Diet and Weight Loss Strategies for the Dyslipidemic Patient - Rebecca Reeves, DrPh, RD |
| Noon | Adjourn |
 |